VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
CYHCommunity Health Systems, Inc.
$3.02$426M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksCYHP/E History

CYH logoCommunity Health Systems, Inc. (CYH) P/E Ratio History

Deep Value

Trading at 0.8x · 0th percentile of 5-year range · Significant discount to historical valuation · Data 2001–2025

Current P/E (TTM)
0.8x
-97% vs 5Y avg
5Y Avg P/E
30.3x
Median 7.9x
5Y Percentile
0th
Lower end of range
PEG Ratio
N/A
5-Year P/E Range
0.8x
Min0.8xMedian7.9xMax342.4x
TTM EPS$-0.65
Price$3.02
Earnings Yield100.00%
EPS Growth (1Y)196.7%
EPS Growth (5Y)-3.0%

Loading P/E history...

P/E Ratio Analysis

As of June 22, 2026, Community Health Systems, Inc. (CYH) trades at a price-to-earnings ratio of 0.8x, with a stock price of $3.02 and trailing twelve-month earnings per share of $-0.65.

The current P/E is 97% below its 5-year average of 30.3x. Over the past five years, CYH's P/E has ranged from a low of 0.8x to a high of 342.4x, placing the current valuation at the 0th percentile of its historical range.

Compared to the Healthcare sector median P/E of 22.1x, CYH trades at a 96% discount to its sector peers. The sector includes 234 companies with P/E ratios ranging from 0.0x to 197.0x.

Relative to the broader market, CYH trades at a notable discount to the S&P 500 median P/E of 24.4x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.

For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our CYH DCF Valuation Calculator →

Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.

CYH Cross-Benchmark Valuation

How does the current P/E compare to sector peers and the broader market?

vs. Healthcare
0.8vs22.1
-96%
Below Sector
vs. S&P 500
0.8vs24.4
-97%
Below Market
PEG Analysis
N/A
P/E ÷ EPS Growth
Based on 197% EPS growth (1Y)

CYH P/E vs Peers

Hospitals and inpatient facilities peers sorted by market cap

CompanyMarket CapP/E RatioPEG RatioEPS Growth (1Y)
THC logoTHCTenet Healthcare Corporation
$15B11.10.34Best-53%
HCA logoHCAHCA Healthcare, Inc.
$84B13.20.63+29%
UHS logoUHSUniversal Health Services, Inc.
$9B6.1Lowest0.38+37%
SEM logoSEMSelect Medical Holdings Corporation
$2B14.0--29%
ENSG logoENSGThe Ensign Group, Inc.
$9B26.31.91+14%
USPH logoUSPHU.S. Physical Therapy, Inc.
$964M44.6--23%
MCK logoMCKMcKesson Corporation
$90B19.6-+49%
CAH logoCAHCardinal Health, Inc.
$52B34.4-+87%Best

Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.

CYH Historical P/E Data (2001–2025)

Quarterly P/E ratios calculated from closing price and TTM EPS

QuarterPeriod EndPriceTTM EPSP/E Ratiovs Avg
FY2025 Q4Dec 31 2025$3.12$3.770.8x-97%
FY2025 Q3-$3.21$2.421.3x-95%
FY2023 Q3Sep 30 2023$2.90$1.801.6x-94%
FY2023 Q2Jun 30 2023$4.40$2.172.0x-92%
FY2022 Q4Dec 31 2022$4.32$0.557.9x-70%
FY2022 Q1-$11.87$2.464.8x-82%
FY2021 Q4Dec 31 2021$13.31$1.727.7x-71%
FY2021 Q3-$11.70$2.954.0x-85%
FY2021 Q2Jun 30 2021$15.44$3.075.0x-81%
FY2021 Q1Mar 31 2021$13.52$3.643.7x-86%
FY2020 Q4-$7.43$4.301.7x-93%
FY2016 Q1-$18.51$0.7624.4x-8%
FY2015 Q4-$26.53$1.3419.8x-25%
FY2015 Q3Sep 30 2015$42.77$2.9414.5x-45%
FY2015 Q2-$62.97$3.0420.7x-22%
FY2015 Q1-$52.28$2.4621.3x-20%
FY2014 Q4Dec 31 2014$53.92$0.7373.9x+179%
FY2014 Q3-$54.79$0.16342.4x+1193%
FY2013 Q4-$39.27$1.5225.8x-2%
FY2013 Q3Sep 30 2013$41.50$1.9121.7x-18%
FY2013 Q2Jun 30 2013$46.88$2.3619.9x-25%
FY2013 Q1Mar 31 2013$47.39$2.9716.0x-40%
FY2012 Q4Dec 31 2012$30.74$2.9610.4x-61%
FY2012 Q3Sep 30 2012$29.14$2.6211.1x-58%
FY2012 Q2Jun 30 2012$28.03$2.969.5x-64%
FY2012 Q1Mar 31 2012$22.24$2.429.2x-65%
FY2011 Q4Dec 31 2011$17.45$2.247.8x-71%
FY2011 Q3Sep 30 2011$16.64$2.656.3x-76%
FY2011 Q2-$25.68$2.5810.0x-62%
FY2011 Q1-$39.99$2.9313.6x-48%
FY2010 Q4Dec 31 2010$37.37$3.0112.4x-53%
FY2010 Q3-$30.97$2.9610.5x-60%
FY2010 Q2Jun 30 2010$33.81$2.8511.9x-55%
FY2010 Q1Mar 31 2010$36.93$2.7613.4x-49%
FY2009 Q4-$35.60$2.6613.4x-49%
FY2009 Q3Sep 30 2009$31.93$2.6112.2x-54%
FY2009 Q2-$25.25$2.4910.1x-62%
FY2009 Q1-$15.34$2.346.6x-75%
FY2008 Q4Dec 31 2008$14.58$2.326.3x-76%
FY2008 Q3-$29.31$0.7240.7x+54%
FY2008 Q2Jun 30 2008$32.98$0.30109.9x+315%
FY2008 Q1Mar 31 2008$33.57$0.3790.7x+243%
FY2007 Q4Dec 31 2007$36.86$0.32115.2x+335%
FY2007 Q3Sep 30 2007$31.44$1.8317.2x-35%
FY2007 Q2Jun 30 2007$40.45$1.8122.3x-16%
FY2007 Q1Mar 31 2007$35.25$1.7819.8x-25%
FY2006 Q4Dec 31 2006$36.52$1.7520.9x-21%
FY2006 Q3Sep 30 2006$37.35$1.6822.2x-16%
FY2006 Q2Jun 30 2006$36.75$2.0517.9x-32%
FY2006 Q1Mar 31 2006$36.15$1.9418.6x-30%
FY2005 Q4Dec 31 2005$38.34$1.7821.5x-19%
FY2005 Q3Sep 30 2005$38.81$1.7422.3x-16%
FY2005 Q2-$37.79$1.6023.6x-11%
FY2005 Q1-$34.91$1.5422.7x-14%
FY2004 Q4Dec 31 2004$27.88$1.5418.1x-32%
FY2004 Q3-$26.68$1.4418.5x-30%
FY2004 Q2Jun 30 2004$26.77$1.4318.7x-29%
FY2004 Q1Mar 31 2004$27.83$1.3620.5x-23%
FY2003 Q4Dec 31 2003$26.58$1.3020.4x-23%
FY2003 Q3-$21.70$1.1219.4x-27%
FY2003 Q2Jun 30 2003$15.94$1.0215.6x-41%
FY2003 Q1Mar 31 2003$16.93$0.9617.6x-33%
FY2002 Q4-$17.02$0.9018.9x-29%
FY2002 Q3Sep 30 2002$22.01$0.8625.6x-3%
FY2002 Q2Jun 30 2002$22.15$0.7629.1x+10%
FY2002 Q1Mar 31 2002$18.27$0.6329.0x+10%
FY2001 Q4Dec 31 2001$21.07$0.4843.9x+66%
FY2001 Q3Sep 30 2001$24.58$0.4257.9x+119%
FY2001 Q2Jun 30 2001$24.38$0.3372.9x+175%

Average P/E for displayed period: 26.5x

Export Data
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

25+ years return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

CYH — Frequently Asked Questions

Quick answers to the most common questions about buying CYH stock.

What is CYH's P/E ratio?

Community Health Systems, Inc. (CYH) trailing twelve-month P/E ratio is 0.8x, based on TTM diluted EPS of $-0.65. The 5-year average P/E is 30.3x and the historical range spans 0.8x to 342.4x.

Is CYH stock overvalued or undervalued?

CYH trades at 0.8x P/E, below its 5-year average of 30.3x. At the 0th percentile of its historical range (0.8x–342.4x), the stock is priced at a discount to its own history.

Is CYH stock expensive?

No, CYH is not expensive on a historical basis. The current P/E of 0.8x is below the 5-year average of 30.3x and sits at the 0th percentile of its valuation range.

What is CYH's historical P/E range?

Over the past 5 years, CYH's P/E ratio has ranged from 0.8x to 342.4x, with a median of 7.9x and an average of 30.3x. The current P/E of 0.8x places the stock at the 0th percentile of this range. Full historical data spans 2001–2025.

How does CYH's P/E compare to the S&P 500?

CYH trades at 0.8x P/E versus the S&P 500 median of 24.4x. The 97% discount to the market suggests lower growth expectations or perceived higher risk.

How does CYH's valuation compare to Healthcare peers?

Community Health Systems, Inc. P/E of 0.8x compares to the Healthcare sector median of 22.1x. The discount suggests lower growth expectations, weaker margins, or higher perceived risk relative to peers. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.

What is CYH's PEG ratio?

CYH PEG ratio is N/A, based on a P/E of 0.8x and EPS growth of 196.7%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.

What is CYH's earnings yield?

CYH earnings yield is 100.00%, the inverse of its 0.8x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.

CYH P/E Ratio History (2001–2025)

Quarterly valuation multiple from closing price and trailing EPS

Current0.8x
Period Avg30.3x
Range0.8x - 342.4x
Change-96%
20 quartersSep 30, 2013 - Dec 31, 2025